Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Total revenue | -0.00%11.5M | -6.81%11.5M | 8.67%12.34M | 11.35M |
| Operating revenue | -0.00%11.5M | -6.81%11.5M | 8.67%12.34M | --11.35M |
| Cost of revenue | -28.01%6.37M | 10.96%8.85M | -27.62%7.97M | 11.01M |
| Gross profit | 93.41%5.13M | -39.25%2.65M | 1,184.03%4.37M | 340.04K |
| Operating expense | -8.23%7.8M | -23.68%8.5M | -8.22%11.14M | 12.14M |
| Selling and administrative expenses | -15.05%5.37M | -21.00%6.32M | -5.08%8M | --8.43M |
| -Selling and marketing expense | 9.64%212.8K | -9.50%194.1K | -57.10%214.47K | --499.9K |
| -General and administrative expense | -15.83%5.16M | -21.31%6.13M | -1.80%7.79M | --7.93M |
| Research and development costs | 14.39%218.31K | -76.66%190.84K | -11.36%817.55K | --922.29K |
| Depreciation amortization depletion | 36.13%512.64K | -20.16%376.59K | -33.21%471.67K | --706.18K |
| -Depreciation and amortization | 36.13%512.64K | -20.16%376.59K | -33.21%471.67K | --706.18K |
| Other operating expenses | 5.44%1.7M | -12.78%1.61M | -11.07%1.85M | --2.08M |
| Operating profit | 54.33%-2.67M | 13.64%-5.85M | 42.58%-6.77M | -11.8M |
| Net non-operating interest income (expenses) | -15,308.56%-475.2K | -104.67%-3.08K | 793.36%66.04K | 7.39K |
| Non-operating interest income | 10.77%26.29K | -71.20%23.73K | 483.74%82.39K | --14.11K |
| Non-operating interest expense | 1,770.11%501.49K | 63.99%26.82K | 143.26%16.35K | --6.72K |
| Other net income (expenses) | -84.13%417.18K | 115.11%2.63M | 68.24%1.22M | 726.31K |
| Special income (charges) | ---2.47K | ---- | ---- | ---7.04K |
| -Gain on sale of property,plant,equipment | ---2.47K | ---- | ---- | ---7.04K |
| Other non-operating income (expenses) | 29.93%862.54K | -45.67%663.86K | 66.63%1.22M | --733.35K |
| Income before tax | 15.33%-2.73M | 41.23%-3.22M | 50.42%-5.49M | -11.06M |
| Income tax | 68.13K | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||
| Net income | 29.45%-3.02M | 21.99%-4.28M | 50.42%-5.49M | -11.06M |
| Net income continuous operations | 13.22%-2.8M | 41.23%-3.22M | 50.42%-5.49M | ---11.06M |
| Net income discontinuous operations | 79.05%-221.09K | ---1.06M | ---- | ---- |
| Noncontrolling interests | ||||
| Net income attributable to the company | 29.45%-3.02M | 21.99%-4.28M | 50.42%-5.49M | -11.06M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | 29.45%-3.02M | 21.99%-4.28M | 50.42%-5.49M | -11.06M |
| Diluted earnings per share | 31.87%-0.0419 | 35.33%-0.0615 | 61.61%-0.0951 | -0.2477 |
| Basic earnings per share | 31.87%-0.0419 | 35.33%-0.0615 | 61.61%-0.0951 | -0.2477 |
| Dividend per share | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |